A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer metabolism by controlling the powerful mTOR growth pathway, tying survival and energy use together. This insight explains why MCL1-targeting drugs can be effective—but also why they sometimes damage the heart. Researchers have now identified a way to reduce that risk, potentially unlocking safer cancer therapies.
source https://www.sciencedaily.com/releases/2026/01/260104202819.htm
Gold 'supraballs' nearly double solar energy absorption in tests
-
Sunbeams contain a lot of energy. But current technology for harvesting
solar power doesn't capture as much as it could. Now, in ACS Applied
Materials & In...
16 hours ago
No comments:
Post a Comment